Pregnancy rate · subfertile women with PCOS
It is very uncertain whether chinese herbal medicine (CHM) plus follicle aspiration plus… changes pregnancy rate compared with follicle aspiration plus ovulation induction (very low certainty).
1 finding from 1 review
Luteinised unruptured follicle syndrome (adverse events) · subfertile women with PCOS
It is very uncertain whether chinese herbal medicine (CHM) plus follicle aspiration plus… changes luteinised unruptured follicle syndrome (adverse events) compared with follicle aspiration plus ovulation induction (very low certainty).
1 finding from 1 review
Outcomesa · women with menopausal symptoms
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Vasomotor symptoms (vasomotor) · women with menopausal symptoms
1 finding from 1 review
Adverse effects · women with menopausal symptoms
It is very uncertain whether CHM changes adverse Effects compared with HT (very low certainty).
1 finding from 1 review
Effectiveness · women with recurrent UTI
It is very uncertain whether CHM changes effectiveness compared with antibiotics (very low certainty).
1 finding from 1 review
Recurrence · women with recurrent UTI
It is very uncertain whether CHM changes recurrence compared with antibiotics (very low certainty).
1 finding from 1 review
Effectiveness · women with recurrent UTI
It is very uncertain whether CHM changes effectiveness compared with CHM (very low certainty).
1 finding from 1 review
Recurrence · women with recurrent UTI
It is very uncertain whether CHM changes recurrence compared with CHM (very low certainty).
1 finding from 1 review
Quality of life · women with recurrent UTI
1 finding from 1 review
Total effectiveness rate (Analysis 1.1) Clinician's rating · atopic eczema
CHM may leads to higher total effectiveness rate (Analysis 1.1) Clinician's rating compared with placebo (low certainty).
1 finding from 1 review
Overall severity score (Analysis 1.3) Clinician's rating. Scale from 1 to 80 · atopic eczema
1 finding from 1 review
Adverse events (Analysis 1.7) Participant's report · atopic eczema
CHM may leads to lower adverse events (Analysis 2.6) Participant's reports compared with drugs (low certainty).
1 finding from 1 review
Itching VAS (Analysis 1.2) Participant's rating. Scale from 1 to 10 · atopic eczema
1 finding from 1 review
Overall severity score (Analysis 1.3) Clinician's rating. Scale from 1 to 80 · atopic eczema
1 finding from 1 review
QoL · atopic eczema
1 finding from 1 review
Adverse events (Analysis 1.7) Participant's report · atopic eczema
CHM showed no clear difference in adverse events (Analysis 1.7) Participant's report compared with placebo (low certainty).
1 finding from 1 review
Total effectiveness rate (Analysis 1.1) Clinician's rating · atopic eczema
It is very uncertain whether CHM changes total effectiveness rate (Analysis 2.1) Clinician's rating compared with drugs (very low certainty).
1 finding from 1 review
Total effectiveness rate with subgroup analysis ‐ individualised treatment Clinician's rating · atopic eczema
CHM may leads to higher total effectiveness rate with subgroup analysis ‐ individualised… compared with drugs (low certainty).
1 finding from 1 review
Total effectiveness rate with subgroup analysis ‐ non‐individualised treatment Clinician's rating · atopic eczema
It is very uncertain whether CHM changes total effectiveness rate with subgroup analysis ‐ non‐individualised… compared with drugs (very low certainty).
1 finding from 1 review